54
Participants
Start Date
March 19, 2021
Primary Completion Date
May 20, 2024
Study Completion Date
P. Hertsen Moscow Oncology Research Institute, Moscow
Jiaxing University
UNKNOWN
P. Herzen Moscow Oncology Research Institute
OTHER_GOV